Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Health Canada states 6 months to 2 years for Din

<< Previous

Bullboard Posts

Next >>

Comment by Realnewsalways1on Oct 20, 2021 10:31am

50 Views

Post# 34026664

RE:Health Canada states 6 months to 2 years for Din

Sam tha man.....Reduvo has been approved in many countries around the world and has years of efficacy and safety profile behind it. The review process timeline by HC standards is 180 days fro acceptance of submission which was months ago ...you do the math. We will know in a couple of months one way or another......Nothing in life is a sure thing as you knwo but your approach again is so obvious in your agenda.....Move to another board if you are not invested or if not doing that just change your name when you get shouted doen

<< Previous

Bullboard Posts

Next >>

This profitable gold stock is on its way up